On Tuesday, Corcept Therapeutics Inc (NASDAQ: CORT) opened lower -0.27% from the last session, before settling in for the closing price of $48.34. Price fluctuations for CORT have ranged from $20.84 to $50.07 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 14.14%. Company’s average yearly earnings per share was noted 19.28% at the time writing. With a float of $89.95 million, this company’s outstanding shares have now reached $103.41 million.
The extent of productivity of a business whose workforce counts for 352 workers is very important to gauge. In terms of profitability, gross margin is 98.49%, operating margin of 22.46%, and the pretax margin is 26.3%.
Corcept Therapeutics Inc (CORT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Corcept Therapeutics Inc is 13.91%, while institutional ownership is 83.52%. The most recent insider transaction that took place on Oct 01 ’24, was worth 462,800. In this transaction Chief Development Officer of this company sold 10,000 shares at a rate of $46.28, taking the stock ownership to the 5,796 shares. Before that another transaction happened on Oct 01 ’24, when Company’s Chief Business Officer sold 11,000 for $46.28, making the entire transaction worth $509,080. This insider now owns 22,772 shares in total.
Corcept Therapeutics Inc (CORT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 19.28% per share during the next fiscal year.
Corcept Therapeutics Inc (NASDAQ: CORT) Trading Performance Indicators
Check out the current performance indicators for Corcept Therapeutics Inc (CORT). In the past quarter, the stock posted a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.84. Likewise, its price to free cash flow for the trailing twelve months is 40.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.13, a number that is poised to hit 0.28 in the next quarter and is forecasted to reach 1.87 in one year’s time.
Technical Analysis of Corcept Therapeutics Inc (CORT)
The latest stats from [Corcept Therapeutics Inc, CORT] show that its last 5-days average volume of 0.82 million was inferior to 1.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 48.17%. Additionally, its Average True Range was 1.68.
During the past 100 days, Corcept Therapeutics Inc’s (CORT) raw stochastic average was set at 91.56%, which indicates a significant increase from 67.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.16% in the past 14 days, which was lower than the 39.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.58, while its 200-day Moving Average is $31.01. Now, the first resistance to watch is $48.75. This is followed by the second major resistance level at $49.30. The third major resistance level sits at $49.86. If the price goes on to break the first support level at $47.64, it is likely to go to the next support level at $47.08. The third support level lies at $46.53 if the price breaches the second support level.
Corcept Therapeutics Inc (NASDAQ: CORT) Key Stats
There are currently 104,492K shares outstanding in the company with a market cap of 5.04 billion. Presently, the company’s annual sales total 482,380 K according to its annual income of 106,140 K. Last quarter, the company’s sales amounted to 163,800 K and its income totaled 35,490 K.
